File:The effect of an aging TME on tumor progression.jpg
The_effect_of_an_aging_TME_on_tumor_progression.jpg (708 × 544 pixels, file size: 112 KB, MIME type: image/jpeg)
Captions
Captions
Summary
edit
| Description |
Italiano: The effect of an aging TME on tumor progression. Age-induced changes in the structure and function of the ECM promote the occurrence and development of tumors. The integrity of the ECM is greatly reduced with age, which can promote the development of cancer. In the aging TME, stromal cells are disordered and loosely arranged, which may also lead to tumor progression and metastasis. Moreover, age-induced secretion of SASP, such as the accumulation of several factors, including IL-6, IL-8, and IL-10, is a key factor in inducing tumorigenesis and progression. The aging TME also exhibits an infiltration of immunosuppressive cells, such as MDSCs and Tregs. The increase in immunosuppressive M2 macrophages and N2 neutrophils may further promote immunosuppression, while immunosenescence of effector T cells, NK cells, macrophages, and DCs significantly reduces their cytotoxic activity, leading to tumor escape and tumor progression |
| Date | |
| Source | Lian, Jingyao (2020-11-10). "Immunosenescence: a key player in cancer development". Journal of hematology & oncology 13 (1). Springer Science and Business Media LLC. DOI:10.1186/s13045-020-00986-z. PMID 33168037. PMC: 7653700. ISSN 1756-8722. |
| Author |
Jingyao Lian 1 2, Ying Yue 1 2 3, Weina Yu 1 2, Yi Zhang 4 5 1-Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, 450052, Henan, China. 2-State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou, 450052, Henan, China. 3-Clinical Laboratory, Henan Medical College Hospital Workers, Zhengzhou, 450000, Henan, China. 4-Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, 450052, Henan, China. yizhang@zzu.edu.cn. 5-State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou, 450052, Henan, China. yizhang@zzu.edu.cn. |
Licensing
edit
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 14:54, 14 June 2021 | | 708 × 544 (112 KB) | OppidumNissenae (talk | contribs) | Uploaded a work by Jingyao Lian 1 2, Ying Yue 1 2 3, Weina Yu 1 2, Yi Zhang 4 5 1-Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe East Road, Zhengzhou, 450052, Henan, China. 2-State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou, 450052, Henan, China. 3-Clinical Laboratory, Henan Medical College Hospital Workers, Zhengzhou, 450000, Henan, China. 4-Biotherapy Center and Cancer Center, The First Affiliated Hospital... |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.
File usage on other wikis
The following other wikis use this file:
- Usage on it.wikipedia.org
